NASDAQ:OPRX - OptimizeRx Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$11.2850 +0.54 (+5.03 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$11.2850
Today's Range$10.74 - $11.65
52-Week Range$2.30 - $18.39
Volume73,571 shs
Average Volume103,205 shs
Market Capitalization$135.58 million
P/E Ratio-53.74
Dividend YieldN/A
Beta0.92
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. It has a strategic partnership with Patient Connect to deliver real-time messaging at point-of-care in Europe. OptimizeRx Corporation is based in Rochester, Michigan.

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:OPRX
CUSIPN/A
Phone248-651-6568

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$12.13 million
Book Value$0.64 per share

Profitability

Net Income$-2,100,000.00

Miscellaneous

Employees24
Market Cap$135.58 million
OptionableNot Optionable

OptimizeRx (NASDAQ:OPRX) Frequently Asked Questions

What is OptimizeRx's stock symbol?

OptimizeRx trades on the NASDAQ under the ticker symbol "OPRX."

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (NASDAQ:OPRX) posted its quarterly earnings data on Monday, November, 5th. The company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.01. The business had revenue of $5.42 million for the quarter, compared to analyst estimates of $5.28 million. OptimizeRx had a return on equity of 0.87% and a net margin of 0.54%. View OptimizeRx's Earnings History.

When is OptimizeRx's next earnings date?

OptimizeRx is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for OptimizeRx.

What price target have analysts set for OPRX?

4 brokerages have issued twelve-month price targets for OptimizeRx's stock. Their predictions range from $17.00 to $25.00. On average, they expect OptimizeRx's stock price to reach $20.00 in the next year. This suggests a possible upside of 77.2% from the stock's current price. View Analyst Price Targets for OptimizeRx.

What is the consensus analysts' recommendation for OptimizeRx?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OptimizeRx.

Has OptimizeRx been receiving favorable news coverage?

News stories about OPRX stock have been trending somewhat negative on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. OptimizeRx earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term.

Who are some of OptimizeRx's key competitors?

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the folowing people:
  • Mr. William J. Febbo, CEO & Director (Age 49)
  • Ms. Miriam J. Paramore, Pres (Age 55)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 61)
  • Mr. Terence J. Hamilton, Sr. VP of Sales (Age 53)
  • Mr. James Brooks, Consultant (Age 49)

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $11.2850.

How big of a company is OptimizeRx?

OptimizeRx has a market capitalization of $135.58 million and generates $12.13 million in revenue each year. The company earns $-2,100,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. OptimizeRx employs 24 workers across the globe.

What is OptimizeRx's official website?

The official website for OptimizeRx is http://www.optimizerx.com.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The company can be reached via phone at 248-651-6568 or via email at [email protected]


MarketBeat Community Rating for OptimizeRx (NASDAQ OPRX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about OptimizeRx and other stocks. Vote "Outperform" if you believe OPRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel